Chambal Fertilisers & Chemicals
- Market Cap
- ₹14,886 Cr
- P/E
- 7.79
Key Fundamentals
SmallcapFertilizers & AgrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 25.20%
- Debt to Equity
- 0.16
- EPS (TTM)
- ₹47.70
- Book Value
- ₹283.46
- Market Cap
- ₹14,886 Cr
- P/E (TTM)
- 7.79
- P/B
- 1.31
- ROE
- 20.00%
- Dividend Yield
- 1.34%
- EBITDA
- ₹2,805 Cr
- 52W High
- ₹497.80
- 52W Low
- ₹350.00
- Day Range
- ₹369.30 – ₹373.00
- Volume
- 1,58,971
Peer Comparison
Commodities › Fertilizers & Agrochemicals › Fertilizers
| 1,996.00 | 37.72 | 58,894 | 4.39 | 0.56% | 16.40% | 22.00% | 33,242 | 1,508 | |
| 757.30 | — | 49,003 | 36.91 | 0.03% | −2.94% | 4.02% | 5,769 | −88 | |
| 371.55 | 7.79 | 14,886 | 1.31 | 1.35% | 20.00% | 25.20% | 20,710 | 1,911 | |
| 142.08 | 17.33 | 14,755 | 2.07 | 1.08% | 16.20% | 15.40% | 23,939 | 852 | |
| 195.14 | 43.08 | 8,954 | 9.35 | 0.26% | 31.30% | 19.30% | 2,139 | 203 | |
| 246.17 | 31.52 | 7,610 | 11.14 | 0.21% | 38.20% | 27.20% | 2,649 | 241 | |
| 103.94 | 12.16 | 5,734 | 1.09 | 2.25% | 7.84% | 10.40% | 18,466 | 473 | |
| Median 7 companies | 246.17 | 24.42 | 14,755 | 4.39 | 0.56% | 16.40% | 19.30% | 18,466 | 473 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 46
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 73
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 29
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 71
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 20
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 66
- Strong
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 23.5%
Weaknesses
2- The company has delivered a poor sales growth of 10.3% over past five years.
- Debtor days have increased from 16.1 to 36.4 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 42.18
- Neutral
- MACD (12,26,9)
- −3.78
- Bearish
- SMA (50)
- 390.60
- Bearish
- SMA (200)
- 433.52
- Bearish
As of
Analyst Rating
2 of 3 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +8.73% |
|---|---|
| 5Y | +10.33% |
| 3Y | −9.20% |
| 1Y | +24.92% |
| TTM | +6.32% |
Net profit
| 10Y | +29.52% |
|---|---|
| 5Y | +2.24% |
| 3Y | +23.61% |
| 1Y | +18.44% |
| TTM | +2.63% |
Operating cash flow
| 10Y | Turned positive |
|---|---|
| 5Y | −54.33% |
| 3Y | −65.07% |
| 1Y | −90.10% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +5.70 pp |
|---|---|
| 5Y | −6.46 pp |
| 3Y | +6.40 pp |
| 1Y | −2.06 pp |
| TTM | +0.46 pp |
Revenue by year
| Mar 2017 | ₹7,553 Cr |
|---|---|
| Mar 2018 | ₹7,541 Cr |
| Mar 2019 | ₹10,095 Cr |
| Mar 2020 | ₹12,206 Cr |
| Mar 2021 | ₹12,719 Cr |
| Mar 2022 | ₹16,069 Cr |
| Mar 2023 | ₹27,773 Cr |
| Mar 2024 | ₹17,966 Cr |
| Mar 2025 | ₹16,646 Cr |
| Mar 2026 | ₹20,794 Cr |
Net profit by year
| Mar 2017 | ₹359 Cr |
|---|---|
| Mar 2018 | ₹495 Cr |
| Mar 2019 | ₹585 Cr |
| Mar 2020 | ₹1,226 Cr |
| Mar 2021 | ₹1,748 Cr |
| Mar 2022 | ₹1,566 Cr |
| Mar 2023 | ₹1,034 Cr |
| Mar 2024 | ₹1,276 Cr |
| Mar 2025 | ₹1,649 Cr |
| Mar 2026 | ₹1,953 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Chambal Fertilisers trades at a PE of 7.82x with an ROE of 18.8% and near-zero leverage (debt-to-equity of 0.10) as of 2026-11-17. The stock is down roughly 25% from its 52-week high of ₹497.8 and has delivered a 10-year profit CAGR of 22%, though recent sales growth has turned negative on a 3-year basis at -9%.
- PE of 7.82x is well below typical market multiples, suggesting the stock is priced conservatively relative to its earnings of ₹47.7 EPS (TTM)
- ROE has remained consistently high at 18.8% currently, with a 10-year average of 22% and 5-year average of 19%, indicating sustained capital efficiency
- Debt-to-equity ratio of just 0.10 reflects a nearly debt-free balance sheet, reducing financial risk significantly
- ROCE of 21.82% is strong for a fertiliser company and indicates efficient deployment of total capital employed
- 10-year compounded profit growth of 22% demonstrates a long track record of earnings expansion
- Dividend yield of 1.35% with a consistent payout ratio of 23.5% provides a baseline cash return to shareholders
- Stock has delivered a 10-year CAGR of 21%, reflecting long-term value creation despite recent weakness
- 3-year compounded sales growth is negative at -9%, indicating a meaningful revenue contraction cycle
- TTM profit growth has decelerated sharply to just 3%, down from the 3-year CAGR of 24%, suggesting earnings momentum is fading
- Stock has declined 25% from its 52-week high of ₹497.8 to ₹372.9, reflecting weakening market sentiment
- Debtor days have more than doubled from 16.1 to 36.4 days, signalling deteriorating working capital efficiency and potential collection challenges
- 5-year stock CAGR of 0% means shareholders have seen no capital appreciation over a half-decade holding period
- 5-year compounded sales growth of only 10% (roughly 2% per annum in real terms) reflects limited top-line scalability in a regulated sector
- 1-year stock return of -20% indicates significant near-term underperformance versus broader markets
- As a fertiliser company operating in a subsidy-dependent, government-regulated pricing environment, earnings visibility is inherently tied to policy decisions outside management control
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Chambal Fertilisers delivered steady Q2FY27 results with 6% PAT growth and 9% revenue expansion, underpinned by urea segment strength. The upcoming interim dividend signals healthy cash generation. No material headwinds surfaced in the recent news flow. The near-term outlook appears stable, with investor engagement events likely to provide further visibility on management guidance.
- Q2FY27 PAT up 6% YoY Nov 12
Standalone PAT rose 6% YoY to ₹635 crore for Q2FY27. Revenue grew 9% to ₹7,000 crore, driven by urea segment strength.
- Interim dividend record date set Oct 30
Record date fixed as November 11, 2026 to determine eligibility for an interim dividend, signalling confidence in cash flows.
- Investor meet on Nov 17 Nov 12
Chambal Fertilisers will participate in an annual investor conference in Mumbai on November 17, 2026.
- Q2 earnings call rescheduled Nov 2
Q2FY27 earnings conference call moved to 9:45 am IST on November 4, 2026, from the earlier 11:00 am slot.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,386 | 4,349 | 2,643 | 4,933 | 4,346 | 4,918 | 2,449 | 5,698 | 6,413 | 5,898 | 2,785 | 5,027 | 6,999 |
| Expenses | 4,771 | 3,720 | 2,477 | 4,181 | 3,556 | 4,140 | 2,285 | 4,937 | 5,571 | 5,078 | 2,530 | 4,201 | 6,102 |
| Operating Profit | 615 | 628 | 166 | 752 | 790 | 778 | 163 | 761 | 842 | 821 | 255 | 826 | 898 |
| OPM % | 11% | 14% | 6% | 15% | 18% | 16% | 7% | 13% | 13% | 14% | 9% | 16% | 13% |
| Other Income | 81.76 | 151 | 73 | 86 | 80 | 95 | 86 | 79 | 88 | 36 | 53 | 27 | 51.23 |
| Interest | 46 | 36 | 36 | 40 | 1 | 7 | 0 | 2 | 1 | 1 | 3 | 17 | 22.4 |
| Depreciation | 78 | 79 | 78 | 82 | 83 | 83 | 82 | 84 | 87 | 88 | 90 | 89 | 100 |
| PBT | 573 | 664 | 126 | 716 | 786 | 783 | 168 | 754 | 842 | 768 | 215 | 747 | 826 |
| Tax % | 34% | 31% | 23% | 37% | 32% | 32% | 22% | 27% | 23% | 24% | 21% | 30% | 24% |
| Net Profit | 381 | 459 | 97 | 448 | 536 | 534 | 130 | 549 | 649 | 586 | 169 | 524 | 632 |
| EPS (₹) | 9.15 | 11.04 | 2.42 | 11.19 | 13.39 | 13.34 | 3.25 | 13.70 | 16.19 | 14.64 | 4.22 | 13.07 | 15.77 |
| YoY Sales growth | −37 | −48 | −27 | −12 | −19 | 13 | −7 | 15 | 48 | 20 | 14 | −12 | 9 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,733 | 9,008 | 7,553 | 7,541 | 10,095 | 12,206 | 12,719 | 16,069 | 27,773 | 17,966 | 16,646 | 20,794 | 20,710 |
| Expenses | 8,996 | 8,354 | 6,795 | 6,730 | 8,894 | 10,281 | 10,249 | 13,804 | 25,951 | 15,919 | 14,145 | 18,100 | 17,911 |
| Operating Profit | 737 | 654 | 759 | 811 | 1,200 | 1,925 | 2,470 | 2,265 | 1,822 | 2,047 | 2,501 | 2,694 | 2,799 |
| OPM % | 8% | 7% | 10% | 11% | 12% | 16% | 19% | 14% | 7% | 11% | 15% | 13% | 14% |
| Other Income | 103 | 32 | 133 | 172 | −2 | 192 | 470 | 374 | 222 | 326 | 329 | 240 | 167 |
| Interest | 164 | 267 | 255 | 157 | 247 | 504 | 291 | 109 | 320 | 173 | 48 | 7 | 43 |
| Depreciation | 216 | 111 | 92 | 85 | 119 | 287 | 289 | 300 | 308 | 313 | 330 | 349 | 367 |
| PBT | 459 | 308 | 544 | 740 | 832 | 1,327 | 2,360 | 2,231 | 1,416 | 1,887 | 2,452 | 2,578 | 2,556 |
| Tax % | 39% | 52% | 34% | 33% | 30% | 8% | 26% | 30% | 27% | 32% | 33% | 24% | — |
| Net Profit | 280 | 147 | 359 | 495 | 585 | 1,226 | 1,748 | 1,566 | 1,034 | 1,276 | 1,649 | 1,953 | 1,911 |
| EPS (₹) | 7.08 | 5.31 | 8.70 | 11.99 | 14.18 | 29.46 | 39.76 | 37.62 | 24.85 | 31.84 | 41.17 | 48.76 | 47.70 |
| Div. Payout % | 27% | 36% | 22% | 16% | 14% | 14% | 19% | 20% | 30% | 24% | 24% | 23% | — |
| Sales growth | 9 | −7 | −16 | 0 | 34 | 21 | 4 | 26 | 73 | −35 | −7 | 25 | 6 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 414 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 401 | 401 | 401 | 401 |
| Reserves | 1,837 | 1,451 | 1,707 | 2,089 | 2,467 | 3,123 | 4,833 | 5,983 | 6,652 | 6,873 | 8,327 | 10,007 | 10,956 |
| Borrowings | 4,089 | 5,317 | 4,619 | 6,079 | 9,045 | 10,113 | 3,936 | 4,337 | 3,358 | 1,874 | 99 | 1,068 | 1,772 |
| Other Liabilities | 1,298 | 939 | 1,315 | 877 | 1,997 | 880 | 1,062 | 2,553 | 2,344 | 2,361 | 2,580 | 2,927 | 5,318 |
| Total Liabilities | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 | 18,446 |
| Fixed Assets | 2,948 | 1,793 | 1,162 | 1,234 | 6,905 | 6,701 | 6,480 | 6,358 | 6,262 | 6,423 | 6,221 | 6,110 | 7,509 |
| CWIP | 119 | 639 | 1,712 | 4,135 | 121 | 85 | 161 | 157 | 103 | 184 | 650 | 1,389 | 61 |
| Investments | 30 | 211 | 174 | 207 | 300 | 217 | 298 | 559 | 2,377 | 2,431 | 1,372 | 1,081 | 411 |
| Other Assets | 4,541 | 5,480 | 5,009 | 3,886 | 6,598 | 7,529 | 3,308 | 6,215 | 4,028 | 2,471 | 3,164 | 5,823 | 10,466 |
| Total Assets | 7,638 | 8,123 | 8,057 | 9,462 | 13,925 | 14,533 | 10,247 | 13,289 | 12,770 | 11,509 | 11,407 | 14,402 | 18,446 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,064 | −27 | 1,280 | 1,172 | −1,130 | 827 | 6,944 | −24 | 3,239 | 3,327 | 1,394 | 138 |
| Investing | −149 | −348 | −703 | −1,784 | −1,132 | −462 | −195 | −119 | −1,872 | −382 | 739 | −481 |
| Financing | −937 | 362 | −500 | 564 | 2,263 | −283 | −6,007 | −213 | −1,862 | −2,871 | −2,135 | 543 |
| Net Cash Flow | −22 | −12 | 76 | −49 | 2 | 82 | 742 | −356 | −495 | 73 | −2 | 200 |
| Free Cash Flow | 878 | −665 | 400 | −1,250 | −2,334 | 177 | 6,708 | −188 | 3,045 | 2,718 | 824 | −754 |
| CFO/EBITDA | 159 | 17 | 191 | 170 | −76 | 56 | 295 | 14 | 193 | 179 | 71 | 32 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 119 | 156 | 147 | 123 | 175 | 166 | 34 | 49 | 23 | 4 | 8 | 36 |
| Inventory Days | 48 | 55 | 65 | 63 | 79 | 60 | 39 | 119 | 25 | 42 | 71 | 63 |
| Days Payable | 23 | 28 | 18 | 24 | 59 | 29 | 19 | 57 | 22 | 27 | 25 | 26 |
| Cash Conversion Cycle | 144 | 183 | 193 | 161 | 195 | 198 | 54 | 111 | 26 | 19 | 54 | 73 |
| Working Capital Days | 4 | 8 | 17 | 19 | −5 | 14 | 21 | 39 | 8 | 0 | 30 | 41 |
| ROCE % | 9% | 10% | 11% | 12% | 12% | 14% | 20% | 23% | 16% | 20% | 27% | 25% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Chambal Fertilisers & Chemicals insights
62 extracted metrics across FY11–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Concall · Mar 2026Transcript PPT
- 3 Nov 2026
- 30 Jul 2026
- 14 May 2026
- 10 Feb 2026
- 4 Nov 2025
- 23 Sep 2026
- 22 Sep 2026
- 13 Apr 2026
- 26 Mar 2026
- 17 Mar 2026
- General announcements 12 Nov 2026
Frequently Asked Questions about Chambal Fertilisers & Chemicals
What does Chambal Fertilisers & Chemicals Ltd do?
Where is Chambal Fertilisers & Chemicals Ltd (CHAMBLFERT) listed?
Which sector does Chambal Fertilisers & Chemicals Ltd belong to?
What is the market capitalisation of Chambal Fertilisers & Chemicals Ltd?
What is the PE ratio of Chambal Fertilisers & Chemicals Ltd?
What is the 52-week high and low of Chambal Fertilisers & Chemicals Ltd?
Does Chambal Fertilisers & Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Chambal Fertilisers & Chemicals Ltd?
Company Information
Chambal Fertilisers & Chemicals Ltd is engaged in production of Urea from its own manufacturing plants. It also markets/ deals in other fertilisers and agri-inputs. It also has a Joint Venture for manufacture of Phospohric Acid in Morocco. The company was also engaged in Software business, However, in FY21, it sold assets and transferred certain liabilities of the business to cease the operations of the software business.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CHAMBLFERT.md for Chambal Fertilisers & Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.